|
⚲
|
| Keyboard |
| Western Standard LLC
✚
|
|
|---|---|
| CRD # | 147864 |
| SEC # | 801-108055 |
| CIK # | 0001517666 |
| AUM | 574.9 M (2026-03-30) |
| Employees | 8 (75% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 310-929-4300 |
| Address | 5757 Wilshire Blvd Los Angeles, CA 90036 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($M) |
|---|
| In the News | |
|---|---|
| Wed, 22 Jul 2026 | Western Standard Discloses 5.01% Stake In Hilton Food As Of July 20 — TradingView |
| Wed, 22 Jul 2026 | Western Standard: Welcome to the surveillance state — Canada's new Internet laws belong in Orwell's 1984 — Justice Centre for Constitutional Freedoms |
| Tue, 05 May 2026 | Western Standard Sells Entire Select Medical Position Ahead of $3.9 Billion Buyout — The Motley Fool |
| Thu, 16 Apr 2026 | Trans activist Jessica Simpson files human rights complaints against Western Standard New Media Corp. — Justice Centre for Constitutional Freedoms |
| Fri, 10 Apr 2026 | Western Standard retains counsel to defend against human rights complaints from transgender activist Jessica Simpson — Justice Centre for Constitutional Freedoms |
| Fees and Compensation — Form ADV Part 2A (3/30/2026) [Brochure] |
|---|
ITEM 5 - FEES AND COMPENSATION For each of the Partnerships, Western Standard receives a “Management Fee” equal to 0.375% (approximately 1.50% on an annual basis) of each Limited Partner’s total capital account balance as of the first day of each quarter. The Management Fee is normally paid by deduction from a Limited Partner’s capital account. The Management Fee is prorated for Limited Partner interests held for less than a full quarter. For each of the Partnerships, Western Standard also receives a “Performance Allocation” equal to 20% of the appreciation in each Limited Partner’s capital account during the year. The Performance Allocation is payable only if, and to the extent that, the net capital appreciation of a Limited Partner’s capital account for the year exceeds any net capital depreciation in the capital account (reduced pro rata for any withdrawals) accumulated in prior years (i.e., a “high water mark”). Western Standard may receive Performance Allocations with regard to unrealized appreciation as well as realized gains in Limited Partners’ capital accounts. If a Limited Partner withdraws all or a portion of its capital account on a date other than December 31, a Performance Allocation will be made on the amount withdrawn for the period from the prior January 1 to the date of withdrawal, and any unearned Management Fee will be refunded to the Limited Partner. In its sole discretion for any reason, Western Standard may adjust the Management Fee and Performance Allocation to be borne by any Limited Partner, including to reflect matters such as the amount of the Limited Partner’s investment and its commitment to maintain its investment in the Partnership. Western Standard may also share portions of the Management Fee and Performance Allocation, at its own expense, with persons who refer investors to the Partnerships. The Partnerships may bear additional fees and expenses, which are outlined in each Partnership’s offering memorandum. For the Sub-Advised Fund, Western Standard receives negotiated fees set forth in the Sub-Management Agreement. Termination A Limited Partner may generally withdraw from the Partnership at the end of any calendar quarter, subject to the terms, conditions and limitations described in the respective offering memorandum. |
| Account Minimums and Types of Clients — Form ADV Part 2A (3/30/2026) [Brochure] |
|---|
ITEM 7 - TYPES OF CLIENTS Western Standard provides investment advisory services solely to the Partnerships and the Sub-Advised Fund, which are all private investment funds. Generally, Limited Partners must make a minimum investment of $250,000 into either of the Partnerships. Western Standard may waive that minimum at its discretion. |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Green Dot Corp | 39.8 | ||
| Compass Diversified Holdings | 24.7 | ||
| Teleflex Inc | 22.1 | ||
| Innospec Inc | 16.6 | ||
| Ambac Financial Group Inc | 10.5 | ||
| Aviat Networks Inc | 9.4 | ||
| ANGI Homeservices Inc | 8.3 | ||
| Apartment Investment & Management Co | 6.6 | ||
| YETI Holdings Inc | 5.9 | ||
| Five Below Inc | 5.3 | ||
| View All | |||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | Western Standard Partners LP | [2015-06-25] | 174.5 M | 275.3 M |
| Filed 2025-05-22 (D/A) · Exemption 506(b), 3(c)(1), 3(c) · Minimum $250,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Western Standard Partners QP LP | [2015-06-25] | 43.9 M | 90.9 M |
| Filed 2025-05-22 (D/A) · Exemption 506(b), 3(c)(7), 3(c) · Minimum $250,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 3 | 574.9 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 3 | 574.9 |
| By Discretionary | ||
| Discretionary | 3 | 574.9 |
| Non-Discretionary | 0 | 0.0 |
| Total | 3 | 574.9 |
| By Non-United States Persons | ||
| Non-United States Persons | 208.7 | |
| United States Persons | 366.2 | |
| Total | 3 | 574.9 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Eric Andersen | Executive Officer | 42 | 10 | |
| Western Standard LLC | Executive Officer | 2 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001517666] | |
| 3 | [0001517666] | |
| 4 | [0001517666] | |
| SC 13D | [0001517666] | |
| SC 13G | [0001517666] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Hedge Fund |
| LEI | 25490021H31HVN11CC78 |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Merrimack Pharmaceuticals Inc | |
| Andersen Eric | |
| Western Standard Partners LP | |
| Western Standard LLC | |
| Western Standard Partners QP LP |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-12-28 | Buy | 857 | $13.35 | 11,441 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-12-26 | Buy | 48,693 | $13.15 | 640,313 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-12-07 | Buy | 24,666 | $12.85 | 316,958 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-12-07 | Buy | 76,384 | $12.85 | 981,534 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-11-17 | Buy | 235 | $12.50 | 2,938 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-11-17 | Buy | 65 | $12.50 | 812 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-11-14 | Buy | 39,283 | $12.50 | 491,038 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-11-14 | Buy | 10,887 | $12.50 | 136,088 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-11-13 | Buy | 12,191 | $12.39 | 151,046 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-11-13 | Buy | 3,379 | $12.39 | 41,866 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-11-10 | Buy | 29,803 | $12.32 | 367,173 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-11-10 | Buy | 8,259 | $12.32 | 101,751 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-11-09 | Buy | 7,810 | $12.19 | 95,204 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-11-09 | Buy | 2,165 | $12.19 | 26,391 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-11-08 | Buy | 4,783 | $12.13 | 58,018 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-11-08 | Buy | 9,040 | $12.13 | 109,655 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-08-08 | Buy | 68,431 | $12.00 | 821,172 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-08-08 | Buy | 18,626 | $12.00 | 223,512 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-08-07 | Buy | 49,857 | $12.00 | 598,284 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2023-08-07 | Buy | 84,636 | $12.00 | 1,015,632 |
| showing 20 of 54 most recent transactions | |||||
| Comparable Firms | State | AUM |
|---|---|---|
|
Boxer Capital Management LLC
✚
|
CA | 578.2 M |
|
Cello Capital Management LP
✚
|
NY | 577.2 M |
|
Tabor Asset Management LP
✚
|
NY | 577.2 M |
|
Birnam Oak Advisors LP
✚
|
NY | 577.0 M |
|
Muddy Waters Capital LLC
✚
|
TX | 576.3 M |
|
Untitled Investments LP
✚
|
NY | 574.0 M |
|
Prevatt Capital Ltd
✚
|
571.5 M | |
|
TYRO Capital Management LLC
✚
|
FL | 570.9 M |
|
Lionstone Capital Management LLC
✚
|
NY | 569.7 M |
|
INCA Investments LLC
✚
|
FL | 569.6 M |